Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283088 · ClinicalTrials.gov registry record · Phase 1
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
A Phase 1 study of Stroke, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 130
- Enrollment target
- 7
- Study locations
NCT00283088: Completed Phase 1 study of Stroke, sponsored by University of California, San Diego.
NCT00283088 is a Phase 1 study of Stroke that has completed, run by University of California, San Diego. The registered enrollment target is 130 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283088, a Phase 1 study of Stroke, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 130 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this trial is to evaluate if it is safe to use tissue plasminogen activator (tPA) within 6 hours of stroke onset when combined with hypothermia.
Conditions Studied
Interventions
- PROCEDURE hypothermia
- DRUG tissue plasminogen activator
Study Locations (7)
California
- Stanford Medical Center - Palo Alto
- University of California San Diego, Thornton Hospital - San Diego
- Scripps Mercy Hospital - San Diego
- University of California San Diego, Hillcrest Medical Center - San Diego
Connecticut
- Hartford Hospital - Hartford
Missouri
- Saint Louis University Medical Center - St Louis
Texas
- Herman Memorial Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2003-10 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
What the finished NCT00283088 record still lists
NCT00283088 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which hypothermia is the first listed.
NCT00283088 lists 7 locations in 4 states (California, Connecticut, Missouri).
Frequently Asked Questions
What is clinical trial NCT00283088 about?
NCT00283088 is a clinical study titled "Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke". The purpose of this trial is to evaluate if it is safe to use tissue plasminogen activator (tPA) within 6 hours of stroke onset when combined with hypothermia.
What is the current status of trial NCT00283088?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2003-10. Estimated completion is 2009-05.
What conditions does trial NCT00283088 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT00283088?
The interventions under investigation include: hypothermia (PROCEDURE), tissue plasminogen activator (DRUG).
Who is sponsoring clinical trial NCT00283088?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283088 being conducted?
This trial has 7 study locations across California, Connecticut, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00283088's enrollment target sits among peer trials
130 111th of 454 higher than 342 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Hybrid Robot+FES Stroke Rehabilitation
RECRUITING · Phase 1
-
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
RECRUITING · Phase 1
-
Facilitating Neuroplastic Changes of Acute Stroke Survivors
RECRUITING · Phase 1
-
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
RECRUITING · Phase 1
-
Accelerated rTMS vs. Sham for Stroke Apathy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia